# AMIKACIN SULFATE
> **ANDA218146** · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2024-03-19
## Drug
- **FDA Application Number:** ANDA218146
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMIKACIN SULFATE
- **Generic name:** AMIKACIN SULFATE
- **Active ingredients:** AMIKACIN SULFATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** QILU
- **Manufacturer:** Mullan Pharmaceutical Inc.
- **First approval:** 2024-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218146)
---
*AI Analytics · CC0 1.0*